| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 1.873 | 52 | 0 | 0 | 0 | 818 |
| Total Income - EUR | - | - | - | 0 | 1.873 | 1.584 | 0 | 0 | 0 | 818 |
| Total Expenses - EUR | - | - | - | 4.533 | 6.284 | 8.146 | 1.402 | 1.241 | 1.322 | 2.045 |
| Gross Profit/Loss - EUR | - | - | - | -4.533 | -4.411 | -6.562 | -1.402 | -1.241 | -1.322 | -1.228 |
| Net Profit/Loss - EUR | - | - | - | -4.533 | -4.430 | -6.563 | -1.402 | -1.241 | -1.322 | -1.228 |
| Employees | - | - | - | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dolcoș Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 9.775 | 8.272 | 6.971 | 5.595 | 4.388 | 3.154 | 1.922 |
| Current Assets | - | - | - | 46 | 107 | 226 | 10 | 10 | 10 | 901 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 10 | 0 | 0 | 0 |
| Cash | - | - | - | 46 | 107 | 226 | 0 | 10 | 10 | 901 |
| Shareholders Funds | - | - | - | -4.490 | -8.833 | -15.228 | -16.292 | -17.584 | -18.852 | -19.975 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 14.312 | 17.212 | 22.425 | 21.897 | 21.982 | 22.016 | 22.798 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dolcoș Med S.r.l.